Impacto en las decisiones terapéuticas odontológicas respecto a osteonecrosis maxilar asociada a medicación (ONMM)
American Association of Oral and Maxillofacial Surgeons (AAOMS) define Osteonecrosis Maxilar asociada a Medicación (ONMM) en el año 2022, como “Área ósea necrótica expuesta al medio bucal con más de ocho semanas de permanencia, en presencia de tratamiento crónico con drogas Antirresortivas (AR):...
Saved in:
Main Authors: | Picardo S N, Rodríguez Genta S A, Basilaki J M |
---|---|
Format: | Article |
Language: | Spanish |
Published: |
Universidad Católica de Córdoba
2025-01-01
|
Series: | Revista Methodo |
Subjects: | |
Online Access: | http://methodo.ucc.edu.ar/index.php/methodo/article/view/542 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Medication related osteonecrosis (MRONJ) in the management of CTIBL in breast and prostate cancer patients. Joint report by SIPMO AND SIOMMMS
by: Francesco Bertoldo, et al.
Published: (2025-02-01) -
Information on dental prostheses use and bone resorption in older adults
by: Emily Sarahy Santana Moya, et al.
Published: (2022-12-01) -
Fractura aislada de esternón. Presentación de un caso
by: Yovanny Ferrer Lozano, et al.
Published: (2014-12-01) -
Association of Delayed Denosumab Dosing with Increased Risk of Fractures: A Population-Based Retrospective Study
by: Kyoung Min Kim, et al.
Published: (2024-12-01) -
Conventional Radiography versus Digital Radiography in Endodontic Treatment
by: Rómulo Guillermo López Torres, et al.
Published: (2024-11-01)